Probabilities of OS and EFS. (A) OS for the whole cohort was 89.2% at 12 months and 85.2% at 3 years. (B) OS for MRDs 90.9% and 77.9% at 1 and 3 years, respectively. OS for MUD/MMUD transplants was 94.4% and 88.9% at 1 and 3 years, respectively (P = .51). (C) OS for PID patients was 94.4% and 88.9% at 1 and 3 years, respectively. OS for adults for CGD patients was 90.9% and 81.8% at 1 and 3 years (P = .75). (D) EFS was 89.7% at 1 and 3 years. (E) EFS for MRD transplants was 90.9% at both 1 and 3 years. EFS MUD/MMUD transplants was 88.9% at 1 and 3 years (P = .73). (F) EFS for PID patients was 88.9%; EFS for CGD patients was 90.9% at both 1 and 3 years (P = .65).